87 related articles for article (PubMed ID: 9148861)
21. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors.
Yamada SD; Baldwin RL; Karlan BY
Gynecol Oncol; 1999 Oct; 75(1):72-7. PubMed ID: 10502429
[TBL] [Abstract][Full Text] [Related]
22. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia.
Grasl-Kraupp B; Rossmanith W; Ruttkay-Nedecky B; Müllauer L; Kammerer B; Bursch W; Schulte-Hermann R
Hepatology; 1998 Sep; 28(3):717-26. PubMed ID: 9731564
[TBL] [Abstract][Full Text] [Related]
23. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
24. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
Francis-Thickpenny KM; Richardson DM; van Ee CC; Love DR; Winship IM; Baguley BC; Chenevix-Trench G; Shelling AN
Br J Cancer; 2001 Sep; 85(5):687-91. PubMed ID: 11531253
[TBL] [Abstract][Full Text] [Related]
26. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
27. [Study on the expression and mutation of cadherin 6 gene in human ovarian carcinoma].
Li DR; Li L; Zhang W; Wang LM; Zhang JQ
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):616-9. PubMed ID: 15498191
[TBL] [Abstract][Full Text] [Related]
28. [Transforming growth factor-beta 1 expression in epithelial ovarian neoplasms and its clinical significance].
Huang XY; Wu YL; Liu FY
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):26-8. PubMed ID: 12575227
[TBL] [Abstract][Full Text] [Related]
29. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
Hagedorn H; Sauer U; Schleicher E; Nerlich A
Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
[TBL] [Abstract][Full Text] [Related]
30. Determination of transforming growth factor beta 1 mRNA expression in breast carcinomas by in situ hybridization.
Walker RA; Gallacher B
J Pathol; 1995 Oct; 177(2):123-7. PubMed ID: 7490677
[TBL] [Abstract][Full Text] [Related]
31. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.
Autio-Harmainen H; Karttunen T; Hurskainen T; Höyhtyä M; Kauppila A; Tryggvason K
Lab Invest; 1993 Sep; 69(3):312-21. PubMed ID: 8377473
[TBL] [Abstract][Full Text] [Related]
32. In situ distribution of transforming growth factor alpha in normal human tissues and in malignant tumours of the ovary.
Kommoss F; Wintzer HO; Von Kleist S; Kohler M; Walker R; Langton B; Van Tran K; Pfleiderer A; Bauknecht T
J Pathol; 1990 Nov; 162(3):223-30. PubMed ID: 2266459
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.
Higashi T; Sasagawa T; Inoue M; Oka R; Shuangying L; Saijoh K
Jpn J Cancer Res; 2001 May; 92(5):506-15. PubMed ID: 11376559
[TBL] [Abstract][Full Text] [Related]
34. Aromatase in human common epithelial ovarian neoplasms.
Kaga K; Sasano H; Harada N; Ozaki M; Sato S; Yajima A
Am J Pathol; 1996 Jul; 149(1):45-51. PubMed ID: 8686761
[TBL] [Abstract][Full Text] [Related]
35. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology of human ovarian cancer.
Chow SN; Chien CH; Chen CT
Int Surg; 1996; 81(2):152-7. PubMed ID: 8912082
[TBL] [Abstract][Full Text] [Related]
37. Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.
Eder IE; Stenzl A; Hobisch A; Cronauer MV; Bartsch G; Klocker H
Br J Cancer; 1997; 75(12):1753-60. PubMed ID: 9192977
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor.
Tripathi PK; Chatterjee SK
Cancer Invest; 1996; 14(6):518-26. PubMed ID: 8951356
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
Bartlett JM; Langdon SP; Simpson BJ; Stewart M; Katsaros D; Sismondi P; Love S; Scott WN; Williams AR; Lessells AM; Macleod KG; Smyth JF; Miller WR
Br J Cancer; 1996 Feb; 73(3):301-6. PubMed ID: 8562334
[TBL] [Abstract][Full Text] [Related]
40. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
Sunde JS; Donninger H; Wu K; Johnson ME; Pestell RG; Rose GS; Mok SC; Brady J; Bonome T; Birrer MJ
Cancer Res; 2006 Sep; 66(17):8404-12. PubMed ID: 16951150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
